Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of ARS 213.56 trillion. The enterprise value is 281.74 trillion.

Market Cap	213.56T
Enterprise Value	281.74T

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Nov 7, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.18%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	66.51%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 16.36 and the forward PE ratio is 8.75.

PE Ratio	16.36
Forward PE	8.75
PS Ratio	2.56
PB Ratio	1.73
P/TBV Ratio	n/a
P/FCF Ratio	15.49
P/OCF Ratio	12.29
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.62, with an EV/FCF ratio of 20.44.

EV / Earnings	21.58
EV / Sales	3.11
EV / EBITDA	7.62
EV / EBIT	10.98
EV / FCF	20.44

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.67.

Current Ratio	1.28
Quick Ratio	0.90
Debt / Equity	0.67
Debt / EBITDA	2.42
Debt / FCF	5.97
Interest Coverage	6.59

Financial Efficiency

Return on equity (ROE) is 10.60% and return on invested capital (ROIC) is 7.04%.

Return on Equity (ROE)	10.60%
Return on Assets (ROA)	5.19%
Return on Invested Capital (ROIC)	7.04%
Return on Capital Employed (ROCE)	10.33%
Revenue Per Employee	1.03B
Profits Per Employee	161.21M
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.36

Taxes

Income Tax	-910.02B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +41.40% in the last 52 weeks. The beta is 0.43, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	+41.40%
50-Day Moving Average	9,466.80
200-Day Moving Average	8,183.33
Relative Strength Index (RSI)	59.02
Average Volume (20 Days)	29,099

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.93

Income Statement

In the last 12 months, Pfizer had revenue of ARS 83.41 trillion and earned 13.06 trillion in profits. Earnings per share was 2,293.32.

Revenue	83.41T
Gross Profit	62.40T
Operating Income	23.62T
Pretax Income	12.16T
Net Income	13.06T
EBITDA	32.49T
EBIT	23.62T
Earnings Per Share (EPS)	2,293.32

Full Income Statement

Balance Sheet

The company has 19.91 trillion in cash and 82.28 trillion in debt, giving a net cash position of -62,375.73 billion.

Cash & Cash Equivalents	19.91T
Total Debt	82.28T
Net Cash	-62,375.73B
Net Cash Per Share	n/a
Equity (Book Value)	123.68T
Book Value Per Share	21,682.40
Working Capital	13.72T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.37 trillion and capital expenditures -3,588.28 billion, giving a free cash flow of 13.78 trillion.

Operating Cash Flow	17.37T
Capital Expenditures	-3,588.28B
Free Cash Flow	13.78T
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.81%, with operating and profit margins of 28.31% and 15.66%.

Gross Margin	74.81%
Operating Margin	28.31%
Pretax Margin	14.58%
Profit Margin	15.66%
EBITDA Margin	38.96%
EBIT Margin	28.31%
FCF Margin	16.53%

Dividends & Yields

This stock pays an annual dividend of 340.88, which amounts to a dividend yield of 3.45%.

Dividend Per Share	340.88
Dividend Yield	3.45%
Dividend Growth (YoY)	37.89%
Years of Dividend Growth	3
Payout Ratio	98.75%
Buyback Yield	-0.18%
Shareholder Yield	3.27%
Earnings Yield	6.11%
FCF Yield	6.45%

Dividend Details

Stock Splits

The last stock split was on January 24, 2024. It was a forward split with a ratio of 2.

Last Split Date	Jan 24, 2024
Split Type	Forward
Split Ratio	2

Scores

Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	7